![]() |
市场调查报告书
商品编码
1577196
到 2030 年发酵槽市场预测:按类型、操作模式、规模、材料、微生物、灭菌方法、应用和地区进行的全球分析Fermenters Market Forecasts to 2030 - Global Analysis By Type, Mode of Operation, Scale, Material, Microorganisms, Sterilization Technique, Application and By Geography |
根据Stratistics MRC预测,2024年全球发酵槽市场规模将达17亿美元,预计2030年将达到29亿美元,预测期内复合年增长率为9.2%。
发酵槽是工业发酵过程中用于培养微生物(如酵母、细菌和真菌)以生产各种生物基产品的专用容器。这些产品包括药品、饮料、生质燃料、酵素和其他化学品。发酵槽调节温度、pH 值、氧气水平和营养供应等条件,以促进有效的微生物生长和产品形成。发酵槽有各种尺寸和配置,对于生物技术、製药以及食品和饮料加工等领域的大规模生产至关重要。
根据美国癌症协会杂誌发表的一篇科学论文,预计2022年美国将新增190万癌症病例,609,360人将死于癌症。
生物製药产业需求不断成长
对生物製药的需求不断增长正在推动发酵槽市场的显着成长。由于老年人口的快速增长、医疗保健支出的增加以及生物技术研究的进步,生物製药领域在全球范围内不断扩张,对高效发酵系统的需求不断增加。这些系统能够生产复杂的生技药品,包括单株抗体、重组蛋白和其他生物製药,推动市场成长。
初始成本高
与发酵系统相关的高初始成本是市场成长的主要限制。先进的发酵技术,特别是具有精确控制能力的自动化系统,需要大量的前期投资。这种财务障碍可能会限制采用,特别是在预算有限的小型企业和研究机构中。此外,持续的营运成本以及对专业人员操作和维护这些系统的需求可能会进一步增加总体成本并减缓市场扩张。
增加对生质燃料的投资
环境问题和减少对石化燃料依赖的需求正在推动生质燃料生产投资的增加,为发酵槽应用创造新的途径。随着世界各国政府实施促进生质燃料生产的政策,将生物质转化为乙醇和其他生质燃料的高效发酵系统的需求将会增加,预计为市场提供巨大的成长潜力。
废弃物和产品处理
发酵过程中的废弃物和产品特定管理的挑战对市场成长构成威胁。随着发酵作业规模的增加,产生的废弃物量也随之增加,需要符合环境法规的有效处置方法。这些废弃物处理不当会导致环境污染和健康危害。此外,与实施永续废弃物管理解决方案相关的成本和复杂性可能会阻止一些潜在用户并限制市场扩张。
COVID-19 大流行对发酵槽市场产生了各种影响。儘管它最初扰乱了供应链和製造流程,但它加速了某些行业的需求。生物製药产业加大了对用于疫苗开发和治疗性蛋白质生产的发酵技术的投资。此外,疫情凸显了国内产能的重要性,并有可能推动各地区发酵槽市场的长期成长。
预计批量发酵槽领域在预测期内将是最大的
预计批量发酵槽领域将在预测期内占据市场占有率。分批发酵可以更好地控制生产过程,从而更容易优化和品质保证。此方法特别适用于需要高纯度产品的行业,例如药品和精细化学品。分批发酵槽能够灵活地容纳各种原料,并且能够小批量生产专业批次,这使得它们不仅适合研究和开发,而且也适合商业生产,支持其在多个行业的广泛采用。
预计製药和生物技术产业在预测期内复合年增长率最高
预计製药和生物技术产业在预测期内的复合年增长率最高。这种快速增长的背后是对生物製药的需求增加、个人化医疗的进步以及细胞和基因治疗研究的进步。发酵槽在从抗生素到重组蛋白等多种医药产品的生产中发挥关键作用。医疗保健支出的增加、全球人口老化以及新型生技药品的持续开发进一步推动了该细分市场的扩张,使其成为发酵槽市场创新和成长的关键驱动力。
预计欧洲在预测期内将占据最大的市场占有率。该地区的优势源于其完善的生物製药和生物技术产业、严格的品质标准以及对研发的大量投资。欧洲对永续生产方法(包括生质燃料和生物基化学品)有着浓厚的兴趣,这进一步推动了先进发酵技术的需求。市场领先公司的存在和生物製药生产的支持性法规环境有助于该地区获得巨大的市场占有率。
预计亚太地区在预测期内的复合年增长率最高。这种快速增长的推动因素包括生物技术和医药研究投资的增加、生质燃料需求的增加以及发酵食品意识的增强。中国和印度等国家正在成为生物製药製造的主要参与者,推动了对发酵技术的需求。此外,政府支持生物技术研究和永续能源生产的倡议预计将推动该地区的市场成长,使其成为发酵槽市场扩张的热点。
According to Stratistics MRC, the Global Fermenters Market is accounted for $1.7 billion in 2024 and is expected to reach $2.9 billion by 2030, growing at a CAGR of 9.2% during the forecast period. Fermenters are specialized vessels used in industrial fermentation processes to grow microorganisms for the production of different bio-based products, such as yeast, bacteria, or fungi. These goods may consist of medicines, beverages, biofuels, enzymes, and other chemicals. In order to facilitate effective microbial growth and product formation, fermenters maintain regulated conditions for temperature, pH, oxygen levels, and nutrient supply. They come in a variety of sizes and configurations and are essential for large-scale production in sectors such as biotechnology, pharmaceuticals, and food and beverage processing.
According to a scientific paper published in the American Cancer Society journal, it was estimated that there would be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. in 2022.
Rising demand in the biopharmaceutical industry
The increasing demand for biopharmaceuticals is driving significant growth in the fermenters market. As the biopharmaceutical sector expands globally due to a surge in geriatric population, increased healthcare expenditure, and advancements in biotechnology research, the need for efficient fermentation systems rises. These systems enable the production of complex biologics, including monoclonal antibodies, recombinant proteins, and other biopharmaceutical products, fueling market growth.
High initial costs
The high initial costs associated with fermenter systems pose a significant restraint to market growth. Advanced fermentation technologies, especially automated systems with precise control capabilities, require substantial upfront investments. This financial barrier can limit adoption, particularly among smaller companies or research institutions with budget constraints. Additionally, ongoing operational costs and the need for specialized personnel to operate and maintain these systems further contribute to the overall expense, potentially slowing market expansion.
Rising investment in biofuels
Increasing investments in biofuel production, driven by environmental concerns and the need to reduce dependence on fossil fuels, are creating new avenues for fermenter applications. As governments worldwide implement policies to promote biofuel production, the demand for efficient fermentation systems to convert biomass into ethanol and other biofuels is expected to rise, offering substantial growth potential for the market.
Disposal of waste and by-products
The challenge of managing waste and by-products from fermentation processes poses a threat to the market's growth. As fermentation operations scale up, the volume of waste generated increases, necessitating effective disposal methods that comply with environmental regulations. Improper handling of these wastes can lead to environmental contamination and health hazards. Additionally, the cost and complexity of implementing sustainable waste management solutions may deter some potential users, potentially limiting market expansion.
The COVID-19 pandemic had a mixed impact on the fermenters market. While it initially disrupted supply chains and manufacturing processes, it also accelerated demand in certain sectors. The biopharmaceutical industry saw increased investment in fermentation technologies for vaccine development and production of therapeutic proteins. Additionally, the pandemic highlighted the importance of domestic production capabilities, potentially driving long-term growth in the fermenters market across various regions.
The batch fermenters segment is expected to be the largest during the forecast period
The batch fermenters segment is expected to dominate the market share during the forecast period. Batch fermentation offers greater control over the production process, allowing for easier optimization and quality assurance. This method is particularly favored in industries requiring high-purity products, such as pharmaceuticals and fine chemicals. The flexibility of batch fermenters in handling various feedstocks and their ability to produce smaller, specialized batches make them ideal for research and development as well as commercial production, driving their widespread adoption across multiple industries.
The pharmaceuticals and biotechnology segment is expected to have the highest CAGR during the forecast period
The pharmaceuticals and biotechnology segment is anticipated to register the highest CAGR during the forecast period. This rapid growth is driven by increasing demand for biopharmaceuticals, advancements in personalized medicine, and ongoing research in cell and gene therapies. Fermenters play a crucial role in producing a wide range of pharmaceutical products, from antibiotics to recombinant proteins. The segment's expansion is further fueled by rising healthcare expenditure, an aging global population, and the continuous development of novel biologics, positioning it as a key driver of innovation and growth in the fermenters market.
Europe is anticipated to hold the largest market share over the forecast period. The region's dominance is attributed to its well-established biopharmaceutical and biotechnology industries, stringent quality standards, and significant investments in research and development. Europe's strong focus on sustainable production methods, including biofuels and biobased chemicals, further drives the demand for advanced fermentation technologies. The presence of leading market players and a supportive regulatory environment for biopharmaceutical production contribute to the region's significant market share.
The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period. This rapid growth is driven by increasing investments in biotechnology and pharmaceutical research, rising demand for biofuels, and growing awareness of fermented food products. Countries like China and India are emerging as key players in biopharmaceutical manufacturing, driving demand for fermentation technologies. Additionally, government initiatives supporting biotech research and sustainable energy production are expected to fuel market growth in this region, making it a hotspot for fermenter market expansion.
Key players in the market
Some of the key players in Fermenters Market include Sartorius AG, Eppendorf SE, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Bioengineering AG, Infors HT, Solaris Biotechnology Srl, Applikon Biotechnology B.V., Pierre Guerin SAS, Electrolab Biotech Ltd., Finesse Solutions Inc., Bellco Glass Inc., Cellexus International Ltd., Pall Corporation, Bbi-biotech GmbH, Solida Biotech GmbH, and New Brunswick Scientific Co., Inc.
In May 2023, Thermo Fisher announced an expansion of its single-use technology manufacturing capabilities in China to support growing demand for bioproduction, including fermenters.
In March 2023, Sartorius launched the Biostat STR Generation 3, a new single-use bioreactor for manufacturing scale. It offers improved performance and ease of use for biopharmaceutical production.
In September 2022, Eppendorf introduced the BioFlo 720 bioreactor control system for microbial fermentation and cell culture applications. It offers advanced control capabilities for bench-scale through pilot-scale bioprocessing.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.